Cite
HARVARD Citation
Sunakawa, Y. et al. (n.d.). 483PA biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3. Annals of oncology. p. . [Online].